Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AtriCure (ATRC) Depreciation & Amortization (CF) (2016 - 2025)

Historic Depreciation & Amortization (CF) for AtriCure (ATRC) over the last 17 years, with Q3 2025 value amounting to $3.1 million.

  • AtriCure's Depreciation & Amortization (CF) rose 55.88% to $3.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.0 million, marking a year-over-year increase of 1190.25%. This contributed to the annual value of $11.2 million for FY2024, which is 1854.12% up from last year.
  • As of Q3 2025, AtriCure's Depreciation & Amortization (CF) stood at $3.1 million, which was up 55.88% from $3.1 million recorded in Q2 2025.
  • AtriCure's Depreciation & Amortization (CF)'s 5-year high stood at $3.1 million during Q2 2025, with a 5-year trough of $1.9 million in Q3 2021.
  • In the last 5 years, AtriCure's Depreciation & Amortization (CF) had a median value of $2.4 million in 2023 and averaged $2.4 million.
  • Per our database at Business Quant, AtriCure's Depreciation & Amortization (CF) crashed by 770.38% in 2021 and then skyrocketed by 2611.94% in 2024.
  • Over the past 5 years, AtriCure's Depreciation & Amortization (CF) (Quarter) stood at $1.9 million in 2021, then rose by 17.08% to $2.2 million in 2022, then grew by 13.81% to $2.5 million in 2023, then increased by 18.54% to $2.9 million in 2024, then rose by 4.01% to $3.1 million in 2025.
  • Its Depreciation & Amortization (CF) stands at $3.1 million for Q3 2025, versus $3.1 million for Q2 2025 and $3.0 million for Q1 2025.